Andreas Harloff
Overview
Explore the profile of Andreas Harloff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
1800
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Y, Rivier C, Mora S, Torres Lopez V, Payabvash S, Sheth K, et al.
J Am Heart Assoc
. 2025 Feb;
14(4):e037930.
PMID: 39921496
Background: Dementia and disability are highly prevalent after spontaneous intracerebral hemorrhage (ICH). Previous studies categorizing ICH by large anatomic boundaries have demonstrated that lobar ICH is associated with dementia, while...
2.
Harloff A, Blazhenets G, Fostitsch J, Strecker C, Dersch R, Mayerhofer E, et al.
EJNMMI Res
. 2024 Nov;
14(1):116.
PMID: 39572471
Background: Symptoms in acute cerebral sinus venous thrombosis (CSVT) are highly variable, ranging from headaches to fatal stroke, and the basis for this high inter-individual variability is poorly understood. The...
3.
Strecker C, Krafft A, Saam T, Huellebrand M, Ludwig U, Hennemuth A, et al.
AJNR Am J Neuroradiol
. 2024 Nov;
PMID: 39547801
Background And Purpose: Complicated American Heart Association (AHA) lesion type VI plaques (cCAPs), characterized by the presence of intraplaque hemorrhage, surface defect or thrombus, are strongly associated with ischemic stroke...
4.
Manini C, Hullebrand M, Walczak L, Nordmeyer S, Jarmatz L, Kuehne T, et al.
J Cardiovasc Magn Reson
. 2024 Aug;
26(2):101081.
PMID: 39127260
Background: Four-dimensional cardiovascular magnetic resonance flow imaging (4D flow CMR) plays an important role in assessing cardiovascular diseases. However, the manual or semi-automatic segmentation of aortic vessel boundaries in 4D...
5.
Rahlfs H, Hullebrand M, Schmitter S, Strecker C, Harloff A, Hennemuth A
J Med Imaging (Bellingham)
. 2024 Jul;
11(4):044503.
PMID: 39006308
Purpose: Atherosclerosis of the carotid artery is a major risk factor for stroke. Quantitative assessment of the carotid vessel wall can be based on cross-sections of three-dimensional (3D) black-blood magnetic...
6.
Chen Y, Rivier C, Mora S, Torres Lopez V, Payabvash S, Sheth K, et al.
Eur Stroke J
. 2024 Jun;
:23969873241260154.
PMID: 38880882
Background: Predicting functional impairment after intracerebral hemorrhage (ICH) provides valuable information for planning of patient care and rehabilitation strategies. Current prognostic tools are limited in making long term predictions and...
7.
Schuchardt F, Lutzen N, Kuchlin S, Reich M, Lagreze W, Mast H, et al.
Neuroradiology
. 2024 Apr;
66(7):1161-1176.
PMID: 38676750
Purpose: Intracranial hypertension (IH) frequently complicates cerebral venous thrombosis (CVT). Distinct neuroimaging findings are associated with IH, yet their discriminative power, reversibility and factors favoring normalization in prospective CVT patients...
8.
Schuchardt F, Krafft A, Miguel Telega L, Kuchlin S, Lagreze W, Demerath T, et al.
Clin Neuroradiol
. 2024 Jan;
34(2):391-401.
PMID: 38277058
Purpose: To quantify the effects of CSF pressure alterations on intracranial venous morphology and hemodynamics in idiopathic intracranial hypertension (IIH) and spontaneous intracranial hypotension (SIH) and assess reversibility when the...
9.
Mayerhofer E, Parodi L, Narasimhalu K, Harloff A, Georgakis M, Rosand J, et al.
J Am Heart Assoc
. 2023 Oct;
12(20):e031566.
PMID: 37830349
Background Genetic and nongenetic factors account for the association of family history with disease risk. Comparing adopted and nonadopted individuals provides an opportunity to disentangle those factors. Methods and Results...
10.
Mayerhofer E, Parodi L, Narasimhalu K, Wolking S, Harloff A, Georgakis M, et al.
Int J Stroke
. 2023 Jul;
19(1):84-93.
PMID: 37489815
Background: Valproate is a candidate for ischemic stroke prevention due to its anti-atherosclerotic effects in vivo. Although valproate use is associated with decreased ischemic stroke risk in observational studies, confounding...